We have just published our latest review about the role of KLK3 as an activator of VEGF-C and VEGF-D in prostate cancer. Prostate cancer is one of the most common cancers in males. It is not a question whether you will get it but only when.

I am having a new attempt at learning Finnish! Until very recently, my career has progressed in Meilahti at the Faculty of Medicine, University of Helsinki.

There are about 10-11 Mio. foreigners living in Germany (12/2019) which is about 13% of the population.